SCHEMBL6757259

SCHEMBL6757259

COc1ccc(-c2nc3cccnc3[nH]2)cc1[AsH2]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
CYP1A1 P04798 2/20 0.44
CYP1B1 Q16678 2/20 0.44
RIPK1 Q13546 2/20 0.43
ALOX5 P09917 1/20 0.42
EPHX2 P34913 1/20 0.42
HPSE Q9Y251 3/20 0.42
AURKA O14965 2/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
CYP1A2 P05177 1/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283130 0.85 KDM4E (0.46) GUSBKDM4EALDH1A1HPGDCYP1A1
SCHEMBL4717804 0.80 PDGFRB (0.51) GUSBKDM4EALDH1A1HPGDCYP1A1
SCHEMBL6283126 0.80 PARP1 (0.52) GUSBKDM4EALDH1A1HPGDCYP1A1
SCHEMBL22291215 0.79 AMY1A (0.54) RIPK1AMY1A
SCHEMBL6286122 0.78 CDK4 (0.49) GUSBKDM4EALDH1A1HPGDCYP1A1
SCHEMBL7395145 0.77 GUSB (0.47) GUSBKDM4EALDH1A1HPGDCYP1A1
SCHEMBL9975911 0.76 HPSE (0.41) KDM4EALDH1A1HPGDEPHX2HPSE
SCHEMBL2624651 0.76 HPSE (0.64) ALDH1A1HPSENPC1PKMRAB9A
SCHEMBL711485 0.75 PDE2A (0.52) GUSBKDM4EALDH1A1HPGDRIPK1
SCHEMBL10206881 0.74 AMY1A (0.56) KDM4EAURKACCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014759-A1 6,5-Fused bicyclic heterocycles PICARD JOSEPH ARMAND (US) 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014759-A1 6,5-Fused bicyclic heterocycles ALOX15, ALOX5, ALOX15B GUSB 2150/4885KDM4E 2221/4885ALDH1A1 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.